(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMPLAVAX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMPLAVAX

ST13

US500000079233134

Class

5, 10

Filing

79233134

Registration

5706102

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

06/11/2026

Trademark type

Word

Nice classes

5, 10

Filing date

03/20/2018

Registration date

03/26/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2025

Last transaction

06/11/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

HUSSAIN, TASNEEM

Law office

M90

Current location

TMO LAW OFFICE 118

Holders and representatives

Holders

Enesi Pharma Limited
Enesi Pharma Limited

Representatives

Rebecca A Liebowitz VENABLE LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune diseases; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccinesprophylactic vaccinestherapeutic vaccines; contraceptive preparations and substances

Class 10

Surgicalmedicaldental and veterinary apparatus and instrumentsdrug delivery systems for delivery of drugs and vaccines; needle-free drug delivery systems sold empty; actuator devicesmedical solid dose injectors sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical needle-free injection systemsneedle-free injectorsinjection devices for administering drugs and vaccines sold empty; drug delivery injection devices for administering drugs and vaccinesmedical injectorsneedle-free injectors and structural parts therefor sold empty; actuator devices for use in drug delivery deviceshandheld spring-powered devices in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices in the nature of drug and vaccine delivery systems sold empty to contain pharmaceutical preparations and substances for therapeuticprophylactic and diagnostic use; replacement parts for all the aforesaid goods

Publications

History of USPTO decisions and trademark events.

35 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

06/10/2026

C71T

CANCELLED SECTION 71

10/10/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/26/2024

CCON

COUNTERCLAIM OPP. NO. 999999

06/04/2020

C.7C

NEW CERTIFICATE UNDER SECTION 7 - PROCESSED

01/03/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/09/2019

ES7R

TEAS SECTION 7 REQUEST RECEIVED

11/05/2019

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/03/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/16/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/30/2019

FIMP

FINAL DISPOSITION PROCESSED

07/30/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/26/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

03/26/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/08/2019

PUBO

PUBLISHED FOR OPPOSITION

01/08/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/19/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/14/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/01/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2018

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/31/2018

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/03/2018

GNFR

FINAL REFUSAL E-MAILED

10/03/2018

CNFR

FINAL REFUSAL WRITTEN

10/03/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/25/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/25/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/25/2018

RFNP

REFUSAL PROCESSED BY IB

07/27/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/12/2018

RFRR

REFUSAL PROCESSED BY MPU

07/12/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/03/2018

CNRT

NON-FINAL ACTION WRITTEN

07/02/2018

DOCK

ASSIGNED TO EXAMINER

06/29/2018

MAFR

APPLICATION FILING RECEIPT MAILED

06/12/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/07/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/31/2018

Continuous trademark protection

Get notified about every new filing that threatens IMPLAVAX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.